Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

Compare

11.06

+0.24 (2.22%)

At close: Feb 11, 2026, 4:00 PM EST

11.07

+0.01 (0.09%)

After-hours: Feb 11, 2026, 4:32 PM EST

Entrada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	93.29	101.21	67.6	45.16	291.06	39.05
Short-Term Investments	233.55	318.79	284.37	143.56	-	-
Cash & Short-Term Investments	326.84	420	351.97	188.71	291.06	39.05
Cash Growth	-27.26%	19.33%	86.51%	-35.16%	645.46%	131.80%
Accounts Receivable	1.2	3.68	5.88	-	-	-
Other Receivables	2	1.8	1.7	0.6	-	-
Receivables	3.2	5.48	7.58	0.6	-	-
Prepaid Expenses	8.22	14.16	10.22	20.56	7.64	0.9
Other Current Assets	-	0.4	-	-	-	-
Total Current Assets	338.26	440.04	369.77	209.88	298.7	39.95
Property, Plant & Equipment	70.53	82.05	92.68	33.02	6.26	3.04
Other Long-Term Assets	4.11	4.23	6.74	9.16	0.87	0.54
Total Assets	412.9	526.32	469.19	252.06	305.83	43.53
Accounts Payable	3.17	4.26	3.28	5.99	0.71	1.6
Accrued Expenses	14.81	12.3	10.32	7.15	5.53	1.64
Current Portion of Leases	4.35	7.56	7.91	8.41	-	-
Current Income Taxes Payable	0.62	0.67	4.02	-	-	-
Current Unearned Revenue	0.35	13.65	132.26	-	-	-
Other Current Liabilities	0.72	1.04	1	0.43	0.49	0.12
Total Current Liabilities	24.02	39.48	158.8	21.97	6.72	3.36
Long-Term Leases	48.05	51.65	60.32	17.53	-	-
Long-Term Unearned Revenue	0.11	6.51	7.72	-	-	-
Other Long-Term Liabilities	-	-	-	-	0.4	-
Total Liabilities	72.18	97.64	226.83	39.5	7.12	3.36
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	574.02	558.06	437.13	402.89	392.38	1.02
Retained Earnings	-233.93	-129.34	-194.97	-188.29	-93.67	-42.51
Comprehensive Income & Other	0.62	-0.04	0.2	-2.06	-	-
Total Common Equity	340.72	428.68	242.36	212.55	298.72	-41.49
Shareholders' Equity	340.72	428.68	242.36	212.55	298.72	40.17
Total Liabilities & Equity	412.9	526.32	469.19	252.06	305.83	43.53
Total Debt	52.4	59.21	68.23	25.94	-	-
Net Cash (Debt)	274.44	360.79	283.74	162.78	291.06	39.05
Net Cash Growth	-29.27%	27.16%	74.31%	-44.08%	645.46%	131.80%
Net Cash Per Share	6.66	9.25	8.59	5.20	46.44	35.33
Filing Date Shares Outstanding	35.86	35.63	32.33	33.08	31.25	1.41
Total Common Shares Outstanding	35.86	35.61	32.17	31.39	31.22	1.24
Working Capital	314.24	400.56	210.98	187.9	291.98	36.59
Book Value Per Share	9.50	12.04	7.53	6.77	9.57	-33.35
Tangible Book Value	340.72	428.68	242.36	212.55	298.72	-41.49
Tangible Book Value Per Share	9.50	12.04	7.53	6.77	9.57	-33.35
Machinery	18.39	18.42	15.26	8.54	6.12	2.16
Construction In Progress	-	-	-	0.58	-	-
Leasehold Improvements	0.19	1.93	1.86	1.86	1.56	1.25

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q